Terpenes and derivatives as a new perspective for pain treatment: a patent review

Bibliography

• Khazir J, Mir BA, Mir SA, et al. Natural products as lead compounds in drug discovery. J Asian Nat Prod Res 2013;15(7):764-88
   Web of Science ®Google Scholar
• Wachtel-Galor S, Benzie IFF. Herbal medicine: an introduction to its history, usage, regulation, current trends, and research needs. In: Benzie IFF, Wachtel-Galor S, editors. Herbal medicine: biomolecular and clinical aspects. 2nd edition. CRC Press; Boca Raton (FL); 2011
   Google Scholar
• Mishra BB, Tiwari VK. Natural products in drug discovery: clinical evaluations and investigations. Oppor Chall Scope Nat Prod Med Chem 2011;1:1-61
   Google Scholar
• Cragg GM, Newman DJ. Natural products: a continuing source of novel drug leads. Biochim Biophys Acta 2013;1(6):3670-95
   Google Scholar
• Chang T-H, Hsieh F-L, Ko T-P, et al. Structure of a heterotetrameric geranyl pyrophosphate synthase from mint (Mentha piperita) reveals intersubunit regulation. Plant Cell 2010;22(2):454-67
   PubMedGoogle Scholar
• Dewick PM. Medicinal natural products biosynthetic approach. Wiley; Chichester; 2009
   Google Scholar
• Paduch R, Kandefer-Szerszeń M, Trytek M, et al. Terpenes: substances useful in human healthcare. Arch Immunol Ther Exp (Warsz) 2007;55(5):315-27
   PubMed Web of Science ®Google Scholar
• Wang G, Tang W, Bidigare RR. Terpenoids as therapeutic drugs and pharmaceutical agents. In: Zhang L, Demain AL, editors. Natural products. Humana Press, Totowa, New Jersey; 2005. p. 197-227
   Google Scholar
• Feucht CL, Patel DR. Analgesics and anti-inflammatory medications in sports: use and abuse. Pediatr Clin North Am 2010;57(3):751-74
   PubMed Web of Science ®Google Scholar
• De Sousa DP. Analgesic-like activity of essential oils constituents. Molecules 2011;16(12):2233-52
   PubMedGoogle Scholar
• Institute of Medicine (US) Committee on Advancing Pain Research C. Introduction. 2011
   Google Scholar
• Woolf CJ. Overcoming obstacles to developing new analgesics. Nat Med 2010;16(11):1241-7
   PubMed Web of Science ®Google Scholar
• Guimarães AG, Quintans JSS, Quintans LJ Jr. Monoterpenes with analgesic activity–a systematic review. Phytother Res 2013;27(1):1-15
   PubMed Web of Science ®Google Scholar
• London J, Gibson JO. Therapeutic composition for treatment of cuts, burns and abrasions. US4784842; 1988
   Google Scholar
• Seiwa Pharmaceutical Ltd. Analgetic agent. EP0827747; 1998
   Google Scholar
• Center Pharmaceutical Chemistry. Compositions obtained from Mangifera indica L. WO038699; 2000
   Google Scholar
• Papaprodromou AD. Oregano-based therapeutic composition. US6203796; 2001
   Google Scholar
• Gen Cosmetics Corp. Pain relief composition and method of relieving pain. US6444238; 2002
   Google Scholar
• Enrovita AS. Novel synergistic compositions containing aromatic compounds and terpenoids present in Alpinia galanga. US157204; 2003
   Google Scholar
• Small R. Topical compositions and methods for treating pain. US142911; 2004
   Google Scholar
• Bothma, Zelpy 2549 Ltd. Compositions comprising sesquiterpene compounds for use in the Prophylaxis or treatment of pain. WO066305; 2007
   Google Scholar
• Gelstat Corp. Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms. US7192614; 2007
   Google Scholar
• Sk Chemicals Co Ltd. Extraction and purification method of active constituents from stem of lonicera japonica thunb., its usage for anti-inflammatory and analgesic drug. US7314644; 2008
   Google Scholar
• McLellan, Origin Biomed, Inc. Homeopathic composition comprising hypericum perforatum extract and essential oils for the treatment of neuropathic pain. WO057295; 2010
   Google Scholar
• Pianowski, Ache Lab Farmaceuticos SA. Alpha-humulene for use in the prophylaxis or treatment of inflammatory pain or oedema. EP1809268; 2011
   Google Scholar
• Mclellan A, Greenway F. Composition and method for inhibition of nerve transmission. US257255; 2011
   Google Scholar
• Mclellan A, Greenway F. Compositions comprising terpene compounds for treating negative sensory phenomena. US144191; 2011
   Google Scholar
• Frome, National Pain Institute, Inc. Diagnosis and treatment of various neuralgias. US5260313; 1993
   Google Scholar
• Reed, Neuroquest, Inc. Terpenoid analogues and uses thereof for treating neurological conditions. WO034232; 2012
   Google Scholar
• McLellan, Neuroquest, Inc. Terpene Analogues and uses thereof for treating neurological conditions. WO008093; 2013
   Google Scholar
• Harvard College. Use of huperzine for neuropathic pain. US8193212; 2012
   Google Scholar
• University of California. Pseudopterosin and synthetic derivatives thereof. US4849410; 1989
   Google Scholar
• University of California. Anti-inflammatory compounds derived from pseudopterogorgia elisabethae. WO044191; 2002
   Google Scholar
• BMB Patent Holding Corp. Therapeutic compositions and methods of treatment with capsianoside-type compounds. WO052183; 2008
   Google Scholar
• Parmar SK, Sharma TP, Airao VB, et al. Neuropharmacological effects of triterpenoids. Phytopharmacology 2013;4:354-72
   Google Scholar
• Laboratoires Sarget. Chrysanthellum plant extract. US4146615; 1979
   Google Scholar
• Sigma-Tau Pharmaceutical Industry. Triterpene saponins having anti-inflammatory, mucolytic and antiedemic activities, process for the preparation thereof and pharmaceutical compositions containing them. US4879376; 1989
   Google Scholar
• Gokaraju G, Gokaraju R, Golakoti T, et al. Synergistic anti-inflammatory and antioxidant dietary supplement compositions. WO120220; 2008
   Google Scholar
• Biotechnology Res Corp. Triterpenoid compounds and methods of use thereof. US288169; 2011
   Google Scholar
• Hong Kong Baptist University. Saponins derived from ilex pubescens and method of purifying the same. US7544668; 2009
   Google Scholar
• Griffith University, Jarlmadangah Buru Aboriginal Corp. Analgesic compounds, extracts containing same and methods of preparation. US7618946; 2009
   Google Scholar
• Prados, Granada University, Biomaslinic S.I. Use of Maslinic Acid for the Treatment of Diseases and the Symptoms Thereof by Means of COX-2 Inhibition. WO121992; 2009
   Google Scholar
• Nieto López, Granada University. Use of maslinic acid for treating nociceptive, inflammatory and neurogenic pain. WO015692; 2011
   Google Scholar
• Amazonia Fitomedicamentos LTDA. Pharmaceutical uses of lanosta-8,24-dien-3-ols. MX001411; 2011
   Google Scholar
• Wallace WH. Method of relieving analgesia and reducing inflammation using a cannabinoid delivery topical liniment. US6949582; 2005
   Google Scholar
• Aggarwal SK. Cannabinergic pain medicine: a concise clinical primer and survey of randomized-controlled trial results. Clin J Pain 2013;29(2):162-71
   PubMedGoogle Scholar
• Ou M-C, Hsu T-F, Lai AC, et al. Pain relief assessment by aromatic essential oil massage on outpatients with primary dysmenorrhea: a randomized, double-blind clinical trial. J Obstet Gynaecol Res 2012;38(5):817-22
   PubMedGoogle Scholar
• Garrido-Suárez B, Garrido G, Delgado R, et al. Case series in patients with zoster-associated pain using Mangifera indica L. extract. Forsch Komplementärmed 2011;18(6):345-50
   Google Scholar
• Sengupta K, Alluri KV, Satish AR, et al. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee. Arthritis Res Ther 2008;10(4):R85
   PubMed Web of Science ®Google Scholar
• Dray A. Novel molecular targets in pain control. Curr Opin Anaesthesiol 2003;16(5):521-5
   PubMed Web of Science ®Google Scholar
• Basbaum AI, Bautista DM, Scherrer G, et al. Cellular and molecular mechanisms of pain. Cell 2009;139(2):267-84
   PubMed Web of Science ®Google Scholar
• Calixto JB. Twenty-five years of research on medicinal plants in Latin America: a personal view. J Ethnopharmacol 2005;100(1-2):131-4
   PubMed Web of Science ®Google Scholar
• Rather MA, Bhat BA, Qurishi MA. Multicomponent phytotherapeutic approach gaining momentum: Is the “one drug to fit all” model breaking down? Phytomedicine 2013;21(1):1-14
   PubMedGoogle Scholar
• Santos LP, Aguirre SR, Fernández RC, et al. Effects of VIMANG on various markers of HIV-1 progression in Cuban patients. Rev Cubana Med Trop 2003;55(2):115-18
   PubMedGoogle Scholar
• Borgelt LM, Franson KL, Nussbaum AM, et al. The pharmacologic and clinical effects of medical cannabis. Pharmacotherapy 2013;33(2):195-209
   PubMed Web of Science ®Google Scholar
• Russo EB. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol 2011;163(7):1344-64
   PubMed Web of Science ®Google Scholar
• Abdou WM, Ganoub NA, Sabry E. Synthesis and quantitative structure-activity relationship study of substituted imidazophosphor ester based tetrazolo[1,5-b]pyridazines as antinociceptive/anti-inflammatory agents. Beilstein J Org Chem 2013;9:1730-6
   PubMedGoogle Scholar
• Harvey AL. Natural products in drug discovery. Drug Discov Today 2008;13(19-20):894-901
   PubMed Web of Science ®Google Scholar
• Quintans J de SS, Menezes PP, Santos MRV, et al. Improvement of p-cymene antinociceptive and anti-inflammatory effects by inclusion in beta-cyclodextrin. Phytomedicine 2013;20(5):436-40
   PubMedGoogle Scholar
• Quintans-Júnior LJ, Barreto RSS, Menezes PP, et al. Beta-cyclodextrin-complexed (-)-linalool produces antinociceptive effect superior to that of (-)-linalool in experimental pain protocols. Basic Clin Pharmacol Toxicol 2013;113(3):167-72
   PubMedGoogle Scholar
• Mourtzinos I, Kalogeropoulos N, Papadakis SE, et al. Encapsulation of nutraceutical monoterpenes in beta-cyclodextrin and modified starch. J Food Sci 2008;73(1):S89-94
   Google Scholar